MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$48,007K
Interest income
$6,816K
Income tax benefit
(expense)
$5,637K
Loss before income
tax expense
-$53,659K
Total other income
(expense)
$1,711K
Other income
(expense), net
-$5,105K
Loss from operations
-$55,369K
Total operating
expenses
$55,370K
General and
administrative
$12,239K
Research and development
$43,131K
Back
Back
Income Statement
source: myfinsight.com
Spyre Therapeutics, Inc. (SYRE)
Spyre Therapeutics, Inc. (SYRE)